<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR28">
 <label>28.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ramsey</surname>
    <given-names>ML</given-names>
   </name>
   <name>
    <surname>Nuttall</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Hart</surname>
    <given-names>PA</given-names>
   </name>
   <collab>on behalf of the TIT</collab>
  </person-group>
  <article-title>A phase 1/2 trial to evaluate the pharmacokinetics, safety, and efficacy of NI-03 in patients with chronic pancreatitis: study protocol for a randomized controlled trial on the assessment of camostat treatment in chronic pancreatitis (TACTIC)</article-title>
  <source>Trials</source>
  <year>2019</year>
  <volume>20</volume>
  <issue>1</issue>
  <fpage>501</fpage>
  <pub-id pub-id-type="doi">10.1186/s13063-019-3606-y</pub-id>
  <?supplied-pmid 31412955?>
  <pub-id pub-id-type="pmid">31412955</pub-id>
 </element-citation>
</ref>
